Human health should factor in antibiotic decision, AMA says

Human health should factor in antibiotic decision, AMA says

The nation's peak doctors' group has urged a federal regulator to consider the human health and environmental risks of antibiotic resistance, as it assesses an emergency request to treat farmed salmon with the antibiotic florfenicol in Tasmania.The Australian Medical Association (AMA) has said antimicrobial resistance is one of "the most serious global health threats of the 21st century", and should be considered by the Australian Pesticides and Veterinary Medicines Authority (APVMA) as it assesses Salmon Tasmania's application.The AMA's submission said: "Our concern is that the consequences for human health, the environment and market access are being underestimated, and that health and trade cannot be separated."The drug florfenicol was first used in the state's south-eastern waters in November last year after an emergency permit was approved by the APVMA. That was in response to a bacterial disease that led to the deaths of 15,000 tonnes of salmon in early 2025, and resulted in fish chunks washing up on beaches.Tasmania's farmed Atlantic salmon stocks were hit hard by bacterial outbreaks last year. (Supplied: Bob Brown Foundation)But the regulator revoked the emergency permit in March this year, on the basis of "unacceptable risk of residue exposure to non-target species".The permit was repealed after traces of the antibiotic were detected in wild fish species up to 10 kilometres from the nearest salmon pen in which the antibiotic had been used.Florfenicol was later found in abalone up to 14km away.Salmon Tasmania recently sought the APVMA's approval for another emergency-use permit with the same dose rates and treatment frequency as its previously revoked permit.The previous permit allowed for 10 to 20 milligrams per kilogram of fish per day for 10 consecutive days, with no re-treatment permitted.The APVMA recently sought public feedback on Salmon Tasmania's request. Submissions closed last on Monday, November 16, with the agency expected to make a decision as early as this coming week.Salmon Tasmania chief executive John Whittington said salmon famers agreed with the AMA "that antimicrobial resistance is a serious global health issue"."That is why the industry's first line of defence is vaccination and selective breeding, not antibiotics," Dr Whittington said."Antibiotics are used only to treat diagnosed disease, under veterinary prescription, consistent with growers' legal duty to care for their animals. There is no routine or preventative antibiotic use in Tasmanian salmon farming."Tasmania's salmon industry says florfenicol is its preferred treatment method to combat Piscirickettsia salmonis. (Facebook: Salmon Tasmania)The Tasmanian Health Department has previously said: "There are no reports of adverse human health effects from eating seafood with florfenicol residues."The department said that if a "person chooses to avoid eating finfish that may contain florfenicol residue, they could choose to avoid eating wild finfish caught within 3km of a treated lease for 21 days after treatment finishes".But the AMA said in its submission that florfenicol given in medicated feed to salmon pens cannot be contained, that antibiotic exposure in the aquatic environment favours resistant bacteria and that aquatic workers and divers, fish processors, fishers and coastal communities "may be exposed to resistant organisms"."Resistant infections are harder to treat, prolong illness, increase the use of last-line antibiotics and add to the burden on health systems," the AMA's submission said.Florfenicol was previously used in south-east Tasmania's salmon farms. (Supplied: EPA)The AMA urged the agency to put the drug through a full assessment rather than grant "repeated emergency permits" with independent environmental and human health risk evaluations made public.It said the assessment should consider the risk to human health from resistant bacteria and resistance genes "reaching people through water, seafood and occupational contact".The AMA says there should be a full evaluation of the cumulative environmental and public health effects of repeated, large-scale use, including on wild species, coastal communities, aquaculture workers and fishers.Yet the AMA said in its submission it "is not suggesting that this use will inevitably produce unacceptable resistance, or that importing countries currently require testing for resistance genes."The APVMA is also considering a separate "minor use permit" application from florfenicol manufacturer Abbey Labs.AbbeyFlor florfenicol premix for pigs was initially licensed for use on Atlantic salmon in Tasmania. (Supplied: Abbey Laboratories)A Senate estimates hearing in October heard Abbey Labs' application was for higher dose rates of florfenicol in the south-eastern and eastern biosecurity zones.The AMA recently warned antibiotic resistance in Australia was rising and could threaten the foundations of modern medicine.Antibiotic use expected to fallDr Whittington said much of what the AMA was asking for was already in place or underway."Samples to support research on antibiotic resistance genes in the marine environment have been collected, and in collaboration with IMAS and the EPA a comprehensive research program has been developed," he said."As the AMA notes, florfenicol is not used to treat human infections in Australia. The Director of Public Health has advised there is no evidence of harm to human health from consuming traces of florfenicol."He said antibiotic use had been "very low to zero for most of the past decade", and while it had been used last summer in response to a new disease, P. salmonis, vaccines and selective breeding were being "rapidly progressed"."As these take effect in coming seasons, the industry expects its need for antibiotics for this disease to fall back to close to zero," he said.The Tasmanian Environment Department closed the commercial rock lobster and commercial dive fisheries in parts of the state's south-east for three months to "mitigate trade risks" linked to antibiotic use by the salmon industry.The move is designed to reduce international trade risks linked to the use of the antibiotic oxytetracycline (OTC) in salmon farms in the area.Some of those affected fishers describe the decision as "completely unfair", with "one or two businesses ruining it for everyone else".

Original Source

Read the full article at Abc →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.